Jane Meaney retweeted
Replying to @NewcellsBiotech
@NewcellsBiotech, the developers of a lung epithelium model plan to investigate whether it can be infected by SARS-CoV-2 and, therefore, be used in the fight against #Covid19.
#drugdevelopment #organoids #coronavirus #cv19
Read on: https://teapawt.net/t.co/Enstx89zfR
Jane Meaney retweeted
Louise Brown, daughter of Keith Gadd, with Professor David Kerr are about to appear on #Sky #Skynews #news warning cancer patients of risks of 5FU or capecitabine chemotherapy. Get a DPYD test before chemo to save your life. More at 5FUtestalliance.org
Jane Meaney retweeted
Professor David Kerr and Louise Brown are in the Jack FM radio studio launching the 5FU Test Alliance this morning.
Jane Meaney retweeted
We're looking forward to attending #NCRI2018 in #Glasgow. Drop by our Stand #6 to learn about our pioneering #biomarker technology products that put each individual patient at the centre of #cancer treatment.
Jane Meaney retweeted
The data sheet for #capecitabine states that people at risk of DPYD deficiency should not receive the drug or should be treated with extreme caution. So how can you find out if you are at risk of DPYD deficiency? Learn more in our latest blog https://teapawt.net/t.co/QBz7eLSVxq
Jane Meaney retweeted
What if you could find out which of your patients are at low, intermediate or high risk of #colorectalcancer relapse? ColoProg has been clinically validated in approximately 1,000 Stage II colorectal cancer patients and around 2,500 patients in total.
Jane Meaney retweeted
Bowel cancer screening in England to be offered from age 50 to improve early detection. via @Independent ow.ly/Vy6O30lIdy6 #ColorectalCancer #BowelCancer #Screening
Jane Meaney retweeted
The timeline of #cancer has changed dramatically since the introduction of the first anti-cancer drugs in the 1940s Survival rates have improved significantly and now we have large communities of cancer survivors.
Jane Meaney retweeted
Using our #biomarker tests provides more effective treatment for patients and economic savings for the #healthcare system.
Jane Meaney retweeted
#BMJInfographic by @will_s_t provides a visual summary of the potential direct neuropsychiatric effects of cancer treatments and tumour types: bmj.com/content/bmj/suppl/20…
Jane Meaney retweeted
We're super excited to be shortlisted as a finalist in the Best Diagnostic #Medtech Company category of the @OBN_UK Awards #OBNAwards
Jane Meaney retweeted
Foods That Stop Cancer: Here's a List of 10 Anti-Cancer Vegetables You Should Never Forget to Eat and the great news is .. there not all green. ow.ly/isgu30lg03n #Health #Cancer
Jane Meaney retweeted
Artistic Licence: What did ancient Greek music sound like? Professor Armand D'Angour of @oxfordclassics explains how he recreated the sounds of thousands of years ago: po.st/jRRY6q
Jane Meaney retweeted
Hailed as one of the most exciting and unique #cancer treatments of today, OCB's Founder, David Kerr, professor of cancer medicine @UniofOxford shares a sneak peak into the future of
#ImmunoOncology in #ColorectalCancer medscape.com/viewarticle/877… #KerrOnCancer
Jane Meaney retweeted
OCB's Founder, David Kerr, professor of #cancer medicine @UniofOxford discusses results of a study in #chemotherapy naive patients w/metastatic #colorectalcancer and liver-only or liver-dominant hepatic metastasis in this @Medscape article wb.md/2LKd5OE #whywedoresearch
Jane Meaney retweeted
Our #colorectalcancer cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway.





















